Dual Monoclonal Antibody Therapy for a Severe Asthma Patient

ConclusionsIn some severe allergic asthma patients with persistently high eosinophil counts in peripheral blood and who are considered non- or mild responders to anti-IgE and anti-IL5 administered individually, a combination of the two antibodies covering the entire T2 spectrum may be effective.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research